RHYTHM PHARMACEUTICALS INC's ticker is RYTM and the CUSIP is 76243J105. A total of 118 filers reported holding RHYTHM PHARMACEUTICALS INC in Q4 2022. The put-call ratio across all filers is 0.78 and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $394,150 | +23.1% | 17,193 | -11.4% | 0.24% | +25.8% |
Q2 2023 | $320,137 | +72.5% | 19,414 | +86.6% | 0.19% | +86.3% |
Q1 2023 | $185,607 | -37.6% | 10,404 | +1.8% | 0.10% | -34.2% |
Q4 2022 | $297,636 | +58.3% | 10,221 | -37.4% | 0.16% | +84.5% |
Q1 2022 | $188,000 | +8.7% | 16,317 | -5.6% | 0.08% | +29.2% |
Q4 2021 | $173,000 | +29.1% | 17,290 | +69.0% | 0.06% | +10.2% |
Q3 2021 | $134,000 | -36.5% | 10,229 | -5.0% | 0.06% | -32.2% |
Q2 2021 | $211,000 | 0.0% | 10,765 | +8.3% | 0.09% | -2.2% |
Q1 2021 | $211,000 | -27.5% | 9,939 | +1.7% | 0.09% | -26.4% |
Q4 2020 | $291,000 | -12.6% | 9,772 | -36.5% | 0.12% | -30.9% |
Q3 2020 | $333,000 | -14.6% | 15,384 | -12.0% | 0.18% | -5.4% |
Q2 2020 | $390,000 | +68.1% | 17,484 | +14.8% | 0.18% | +94.7% |
Q1 2020 | $232,000 | -42.1% | 15,224 | -12.8% | 0.10% | +43.9% |
Q4 2019 | $401,000 | +64.3% | 17,450 | +54.3% | 0.07% | +34.7% |
Q3 2019 | $244,000 | -7.2% | 11,308 | -5.3% | 0.05% | -10.9% |
Q2 2019 | $263,000 | +1.2% | 11,938 | +26.1% | 0.06% | -90.1% |
Q1 2019 | $260,000 | -8.1% | 9,468 | -9.9% | 0.55% | +1052.1% |
Q4 2018 | $283,000 | -31.0% | 10,512 | -25.1% | 0.05% | +14.3% |
Q3 2018 | $410,000 | -46.2% | 14,044 | -42.4% | 0.04% | -93.8% |
Q2 2018 | $762,000 | – | 24,374 | – | 0.67% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
MPM ASSET MANAGEMENT LLC | 909,258 | $10,475,000 | 3.58% |
NEA Management Company, LLC | 4,912,306 | $56,590,000 | 1.64% |
RA Capital Management | 4,871,067 | $56,115,000 | 1.22% |
Pinz Capital Management, LP | 148,475 | $1,710,000 | 1.07% |
Samsara BioCapital, LLC | 345,293 | $3,978,000 | 1.00% |
Bell & Brown Wealth Advisors, LLC | 117,400 | $1,352,000 | 0.61% |
Rock Springs Capital Management LP | 1,237,026 | $14,251,000 | 0.36% |
ACT CAPITAL MANAGEMENT, LLC | 27,500 | $317,000 | 0.34% |
Endurant Capital Management LP | 105,792 | $1,219,000 | 0.32% |
Baker Brothers Advisors | 4,125,062 | $47,521,000 | 0.27% |